CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell-based vaccines, today announced the appointment of Ravi Venkataramani, Ph.D., as Vice President, Business Development. Dr. Venkataramani joins Genocea to focus on business and corporate development.
